(RTTNews) - Shares of Fennec Pharmaceuticals Inc. (FENC) touched a new 52-week high of $8.26 yesterday, driven by the company's optimized sales strategy for its lead product, Pedmark, and its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results